CRRTF
Price
$0.36
Change
+$0.01 (+2.86%)
Updated
Aug 15 closing price
Capitalization
6.82M
CVSI
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Aug 15 closing price
Capitalization
7.08M
Interact to see
Advertisement

CRRTF vs CVSI

Header iconCRRTF vs CVSI Comparison
Open Charts CRRTF vs CVSIBanner chart's image
Crescita Therapeutics
Price$0.36
Change+$0.01 (+2.86%)
Volume$700
Capitalization6.82M
CV Sciences
Price$0.04
Change-$0.00 (-0.00%)
Volume$358.8K
Capitalization7.08M
CRRTF vs CVSI Comparison Chart in %
Loading...
CRRTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRRTF vs. CVSI commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRRTF is a Hold and CVSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (CRRTF: $0.35 vs. CVSI: $0.04)
Brand notoriety: CRRTF and CVSI are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CRRTF: 19% vs. CVSI: 113%
Market capitalization -- CRRTF: $6.82M vs. CVSI: $7.08M
CRRTF [@Pharmaceuticals: Generic] is valued at $6.82M. CVSI’s [@Pharmaceuticals: Generic] market capitalization is $7.08M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRRTF’s FA Score shows that 0 FA rating(s) are green whileCVSI’s FA Score has 1 green FA rating(s).

  • CRRTF’s FA Score: 0 green, 5 red.
  • CVSI’s FA Score: 1 green, 4 red.
According to our system of comparison, CVSI is a better buy in the long-term than CRRTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRRTF’s TA Score shows that 4 TA indicator(s) are bullish while CVSI’s TA Score has 5 bullish TA indicator(s).

  • CRRTF’s TA Score: 4 bullish, 3 bearish.
  • CVSI’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, CVSI is a better buy in the short-term than CRRTF.

Price Growth

CRRTF (@Pharmaceuticals: Generic) experienced а -14.29% price change this week, while CVSI (@Pharmaceuticals: Generic) price change was +12.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVSI($7.08M) and CRRTF($6.82M) have the same market capitalization . CVSI YTD gains are higher at: 18.047 vs. CRRTF (-22.655). CVSI has higher annual earnings (EBITDA): -1.21M vs. CRRTF (-1.68M). CRRTF has more cash in the bank: 8.54M vs. CVSI (812K). CRRTF has less debt than CVSI: CRRTF (718K) vs CVSI (1.52M). CRRTF has higher revenues than CVSI: CRRTF (18.1M) vs CVSI (15.3M).
CRRTFCVSICRRTF / CVSI
Capitalization6.82M7.08M96%
EBITDA-1.68M-1.21M139%
Gain YTD-22.65518.047-126%
P/E RatioN/A2.50-
Revenue18.1M15.3M118%
Total Cash8.54M812K1,051%
Total Debt718K1.52M47%
FUNDAMENTALS RATINGS
CRRTF vs CVSI: Fundamental Ratings
CRRTF
CVSI
OUTLOOK RATING
1..100
9819
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9598
PRICE GROWTH RATING
1..100
6048
P/E GROWTH RATING
1..100
9029
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRRTF's Valuation (58) in the null industry is in the same range as CVSI (59). This means that CRRTF’s stock grew similarly to CVSI’s over the last 12 months.

CRRTF's Profit vs Risk Rating (100) in the null industry is in the same range as CVSI (100). This means that CRRTF’s stock grew similarly to CVSI’s over the last 12 months.

CRRTF's SMR Rating (95) in the null industry is in the same range as CVSI (98). This means that CRRTF’s stock grew similarly to CVSI’s over the last 12 months.

CVSI's Price Growth Rating (48) in the null industry is in the same range as CRRTF (60). This means that CVSI’s stock grew similarly to CRRTF’s over the last 12 months.

CVSI's P/E Growth Rating (29) in the null industry is somewhat better than the same rating for CRRTF (90). This means that CVSI’s stock grew somewhat faster than CRRTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRRTFCVSI
RSI
ODDS (%)
Bearish Trend 3 days ago
47%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
50%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
45%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
29%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
68%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
24%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRRTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CVSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFE25.11-0.05
-0.20%
Pfizer
ALTG8.39-0.07
-0.83%
Alta Equipment Group
PAHC30.57-0.39
-1.26%
Phibro Animal Health Corp
XLO0.70-0.01
-1.68%
Xilio Therapeutics
AMKR24.52-0.44
-1.76%
Amkor Technology

CRRTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRRTF has been loosely correlated with LIFD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRRTF jumps, then LIFD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRRTF
1D Price
Change %
CRRTF100%
N/A
LIFD - CRRTF
34%
Loosely correlated
N/A
SIGA - CRRTF
21%
Poorly correlated
-2.28%
ELTP - CRRTF
7%
Poorly correlated
-0.04%
CVSI - CRRTF
7%
Poorly correlated
+2.41%
ECGS - CRRTF
5%
Poorly correlated
+3.70%
More

CVSI and

Correlation & Price change

A.I.dvisor tells us that CVSI and CANN have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVSI and CANN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVSI
1D Price
Change %
CVSI100%
+2.41%
CANN - CVSI
23%
Poorly correlated
-1.70%
ELAN - CVSI
21%
Poorly correlated
+1.07%
BLMH - CVSI
20%
Poorly correlated
-0.90%
CNTMF - CVSI
10%
Poorly correlated
-5.43%
CRRTF - CVSI
7%
Poorly correlated
N/A
More